Cardio Diagnostics Holdings, Inc. (CDIO) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
CDIO Revenue Analysis (2020–2024)
As of March 5, 2026, Cardio Diagnostics Holdings, Inc. (CDIO) generated trailing twelve-month (TTM) revenue of $15,782, reflecting significant decline in growth of -56.6% year-over-year. The most recent quarter (Q3 2025) recorded $2,855 in revenue, down 61.8% sequentially.
Looking at the longer-term picture, CDIO's historical revenue data shows a 3-year CAGR of +238.3%. The company achieved its highest annual revenue of $34,890 in 2024, representing a new all-time high.
When compared to Healthcare sector peers including CAI (+144.9% YoY), VCYT (+16.0% YoY), and ADPT (+42.6% YoY), CDIO has underperformed the peer group in terms of revenue growth. Compare CDIO vs CAI →
Peer Comparison
Compare CDIO's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CDIOCurrent | $15,782 | -56.6% | - | -23977.9% | |
 CAI | $812M | +144.9% | +14.3% | 5.6% | |
 VCYT | $517M | +16.0% | +34.5% | 11.2% | |
 ADPT | $179M | +42.6% | +16.0% | -90.8% | |
 SEER | $14M | +14.5% | +160.6% | -717.7% | |
 IMDX | $2M | +520.9% | - | -3245.1% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $35K | +104.5% | $35K | 100.0% | $-8,365,877 | -23977.9% |
| 2023 | $17K | +1696.3% | $17K | 100.0% | $-7,242,459 | -42440.4% |
| 2022 | $950 | +5.4% | $950 | 100.0% | $-4,548,451 | -478784.3% |
| 2021 | $901 | - | $901 | 100.0% | $-620,448 | -68862.2% |
| 2020 | $0 | - | $0 | - | $-609,164 | - |
See CDIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CDIO Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CDIO vs LLY
See how CDIO stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is CDIO's revenue growth accelerating or slowing?
CDIO revenue declined -56.6% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $15782.00. This reverses the prior growth trend.
What is CDIO's long-term revenue growth rate?
Cardio Diagnostics Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -56.6% is below this long-term average.
How is CDIO's revenue distributed by segment?
CDIO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.